Patents for C12P 21 - Preparation of peptides or proteins (112,499)
02/1989
02/15/1989EP0303028A1 Method for preparing single chain urokinase
02/15/1989EP0302925A1 A method for producing factor viii in high yield
02/14/1989US4804676 Propioxatins a and b
02/14/1989US4804626 Using immobilized monoclonal antibodies
02/14/1989CA1250100A1 Pre-s gene coded peptide hepatitis b immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers
02/09/1989WO1989001050A1 Selective amplification of target polynucleotide sequences
02/09/1989WO1989001041A1 Nucleic acid and methods for the synthesis of novel fusion polypeptides with a phospholipid anchor domain
02/09/1989WO1989001040A1 Attenuated herpes viruses, herpes viruses which include foreign dna encoding an amino acid sequence and vaccines containing same
02/09/1989WO1989001036A1 Recombinant dna expression vectors
02/09/1989WO1989001029A1 Airlift insect cell culture
02/09/1989WO1989001028A1 Serum free media for the growth of insect cells and expression of products thereby
02/09/1989WO1989000999A1 Modular assembly of antibody genes, antibodies prepared thereby and use
02/09/1989WO1989000862A1 Antibodies to angiogenin: immunotherapeutic agents
02/09/1989WO1988009181A3 Monoclonal antibodies neutralizing hiv-1
02/08/1989EP0302838A2 Cloning of the gene coding the isoamylase enzyme and its use in the production of said enzyme
02/08/1989EP0302473A2 Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells
02/08/1989EP0302442A2 Vibriolysin coupling process
02/08/1989EP0302381A1 A fused gene having aequorin gene linked to a functional B-galactosidase gene
02/08/1989EP0302103A1 Colony stimulating factors having reduced levels of carbohydrate
02/08/1989EP0145775B1 A METHOD OF TREATING INTERFERON SENSITIVE DISEASES, AND A METHOD AND A DEVICE FOR PREPARING A $g(g)-INTERFERON CONTAINING PREPARATION
02/08/1989CN1030939A Promoter for expression of exogenous dna in methyltrophic bacteria, process for preparing same and theiruse
02/07/1989US4803169 Assay for human breast cancer
02/07/1989US4803155 Monoclonal antibodies to Sclerotinia homoeocarpa
02/07/1989CA1249785A1 Method for selectively increasing the ratio of single major components of teicoplanin a2 complex
02/07/1989CA1249781A1 Methods of concentrating ligands and active membranes used therefor
02/01/1989EP0302011A2 Monoclonal antibodies and process for the diagnosis of phytophtora infections
02/01/1989EP0301961A1 Specific secretion-excretion-antigens from toxoplasma gondii, expression products therefrom, production processes therefor and their diagnostic and prophylactic applications
02/01/1989EP0301954A2 Cloning method and expression of genes constituting functional organised structures
02/01/1989EP0301670A1 Kluyveromyces as a host strain
02/01/1989EP0301669A1 DNA constructs containing a Kluyveromyces alpha-factor leader sequence for directing secretion of heterologous derivatives
02/01/1989EP0301485A1 Expression vectors and processes using same in the production of cro/beta-galactosidase/PTH fusion proteins and of PTH
02/01/1989EP0301484A1 PTH modifications and therapeutic compositions containing them or consisting of them
02/01/1989EP0301289A1 Humaner Papillomvirus Typ 41
02/01/1989EP0301247A2 De-mannosyl teicoplanin derivatives
02/01/1989EP0138948B1 Dna sequence encoding an exo-signal
02/01/1989CN1030766A Enkastine-glycopeptide of action having inhibitory encephalinase, process for preparing them and pharamaceutical use
01/1989
01/31/1989US4801687 Monoclonal antibody purification process using protein A
01/31/1989US4801686 Suspension, microbial cells, breaking, extraction
01/31/1989US4801542 Expression of biologically active PDGF analogs in eucaryotic cells
01/26/1989WO1989000695A1 Method for the diagnosis of infections with detection of lipopolysaccharide antigens
01/26/1989WO1989000692A1 Second generation monoclonal antibodies having binding specificity to tag-72 and human carcinomas and methods for employing the same
01/26/1989WO1989000603A1 A method for the expression of recombinant genes under stimulation from an inducively expressed activator protein
01/26/1989WO1989000582A2 Human granulocyte-macrophage colony stimulating factor and muteins thereof
01/26/1989WO1989000581A1 Lectines fixing beta-d-galactoside
01/26/1989WO1989000579A1 Purification of gm-csf
01/26/1989WO1988007576A3 Vascular anticoagulant proteins, dnas which code for them, manufacture and application thereof
01/25/1989EP0300988A2 Tissue factor inhibitor
01/25/1989EP0300487A2 Enzymatically inactive, immunologically active beta-galactosidase muteins
01/25/1989EP0300425A2 Method for the production of proteins in a soluble form
01/25/1989EP0300213A1 Hepatitis a viral peptide particle immunogens
01/25/1989EP0300168A2 Process for the glutathione synthesis in yeast
01/25/1989EP0300031A1 Immunosuppressive peptides and methods of use
01/25/1989EP0300030A1 Human proteins having anticoagulant and anti-inflammatory activity
01/25/1989CN1030645A Immunodiagnostic assays using chimeric antigens
01/25/1989CN1030611A Monoclonal antibody specific for adhesion function domain of phagocyte cell surface protein
01/25/1989CN1030610A Monoclonal antibody specific to common determinant site of neutrophils and eosinophils
01/25/1989CN1030609A Protein with 8th activity factor,process for its preparation using genetic engineering cell and pharmaceutical composition containing it
01/25/1989CN1030589A Urinary follicle stimulating hormone
01/24/1989US4800157 Process for producing the A-21978C antibiotics
01/24/1989CA1249222A1 Antibody compositions of therapeutic agents having an extended serum half-life
01/18/1989EP0299828A1 Bactericidal and/or bacteriostatic peptides, process for their isolation, their production and their applications
01/18/1989EP0299810A1 Process for the production of polypeptides by recombinant DNA
01/18/1989EP0299782A2 Expression vectors for the production of human Granulocyte-Macrophage Colony Stimulation Factor in a mammalian cell host(18.05.92)
01/18/1989EP0299746A1 Purification of GM-CSF
01/18/1989EP0299707A2 Glycopeptide antibiotics
01/18/1989EP0299706A2 Nonglycosylated plasminogen activator and method of preparation
01/18/1989EP0299354A2 Monoclonal antibodies against protein E7 of the human papilloma virus type 16, their production process and their use
01/18/1989EP0299303A2 Eucaryotic expression vectors with multimeric enhancer subelements, process for their preparation and use
01/18/1989EP0299242A2 Heterologous viral peptide particle immunogens
01/18/1989EP0299206A2 Recombinant human ADF
01/18/1989EP0299127A1 A method for the expression of recombinant genes under stimulation from an inducively expressed activator protein
01/18/1989EP0299108A1 DNA-molecules coding for FMDH control regions and structured gene for a protein having FMDH-activity and their uses
01/18/1989EP0299057A1 Potentiation of cytotoxic conjugates
01/18/1989CN1030443A Multivalent meningococcal class 1 outer-membrane protein vaccine
01/17/1989US4798807 Monoclonal antibodies and method for detecting dioxins and dibenzofurans
01/17/1989US4798791 Vector for high level gene expression
01/17/1989US4798790 Monoclonal antibody specific for a pigmentation associated antigen
01/17/1989CA1248894A1 Synthetic peptide-based anti-rabies compositions and methods
01/12/1989WO1989000200A1 Peptides and antibodies that inhibit platelet adhesion
01/12/1989WO1989000198A1 Recombinant fibroblast growth factors
01/12/1989WO1989000196A1 Virus proteins having reduced o-linked glycosylation
01/12/1989WO1989000192A1 Production of kallikrein
01/12/1989WO1989000190A1 Monoclonal antibody specific for the adhesion function domain of a phagocyte cell surface protein
01/12/1989WO1989000169A1 Monoclonal antibody specific to a common determinant site of neutrophils and eosinophils
01/12/1989WO1989000163A1 Vaccines against animal parasitic nematodes
01/12/1989WO1989000050A1 Antigen recognized by mca 16-88
01/12/1989WO1989000048A1 Bactericidal and/or bacteriostatic peptides, process for their isolation, their production and their applications
01/12/1989WO1988009818A3 Growth hormone receptor
01/11/1989EP0298807A1 Method for the production of stable cell lines from transgenic animals for the production of specific proteins; tumour cell lines and proteins obtained
01/11/1989EP0298723A1 Recombinant fibroblast growth factors
01/11/1989EP0298633A2 Synthetic polypeptides
01/11/1989EP0298450A2 Hybridoma cell lines, monoclonal antibodies and their use for immunocytochemical detection or fluorescence-activated sorting of cells expressing the c-myb protein and pharmaceutical compositions
01/11/1989EP0298088A1 Production and diagnostic use of antibodies against pancreatic alpha-amylase
01/11/1989CN1030256A Methods and materials for h1v detection and therapy
01/10/1989US4797929 Word recognition in a speech recognition system using data reduced word templates
01/10/1989US4797474 Solubilization of protein aggregates
01/10/1989US4797473 Monoclonal antibodies to unreduced, nonenzymatically-glycated proteins
01/10/1989US4797370 Antigens, bonding, immunology
01/10/1989US4797356 Monoclonal antibodies specific to glactosyltransferase isoenzyme II and their use in cancer immunoassays
01/10/1989CA1248472A1 Monoclonal antibodies specific to in vivo fragments derived from fibrinogen